Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.

NCT00601172 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00601172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00601172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
March 10, 2008
Completion date
April 13, 2009
Enrollment
710 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

nausea and vomiting, chemotherapy-induced